HUMAW Earnings Report
Humacyte reported earnings of per HUMAW share on Nov 6, 2026, falling short of analysts' expectations by
| Report Date | Nov 6, 2026 |
|---|---|
| Forecasted EPS | -$ 0.09 |
| Last Year's EPS | -$ 0.05 |
| EPS YoY Change |
Humacyte reported earnings of per HUMAW share on Nov 6, 2026, falling short of analysts' expectations by
| Report Date | Nov 6, 2026 |
|---|---|
| Forecasted EPS | -$ 0.09 |
| Last Year's EPS | -$ 0.05 |
| EPS YoY Change |
Out of the last 28 earnings reporting periods, Humacyte beat analysts’ expectations 14 times and fell short of expectations 9 time(s). Humacyte reported earnings per share of in the last report surpassing an estimated EPS of -$ 0.09 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 6, 2026 | -$ 0.09 | -$ 0.24 | - | |
| Aug 12, 2026 | -$ 0.11 | -$ 0.16 | $ 0.28 | |
| May 13, 2026 | -$ 0.12 | -$ 0.09 | -$ 0.16 | |
| Mar 27, 2026 | -$ 0.13 | -$ 0.13 | -$ 0.33 | |
| Nov 12, 2025 | -$ 0.15 | -$ 0.11 | -$ 0.48 | |
| Aug 11, 2025 | -$ 0.16 | -$ 0.24 | -$ 0.29 | |
| May 13, 2025 | -$ 0.19 | $ 0.28 | -$ 0.24 | |
| Mar 28, 2025 | -$ 0.25 | -$ 0.16 | -$ 0.25 | |
| Nov 8, 2024 | -$ 0.25 | -$ 0.33 | $ 0.00 | |
| Aug 13, 2024 | -$ 0.24 | -$ 0.48 | -$ 0.22 | |
| May 10, 2024 | -$ 0.23 | -$ 0.29 | $ 0.00 | |
| Mar 22, 2024 | -$ 0.24 | -$ 0.24 | -$ 0.60 | |
| Nov 9, 2023 | -$ 0.25 | -$ 0.25 | $ 0.00 | |
| Sep 30, 2023 | - | $ 0.00 | $ 0.33 | |
| Aug 14, 2023 | -$ 0.22 | -$ 0.22 | $ 0.0003300 | |
| Jun 30, 2023 | - | $ 0.00 | $ 0.00 | |
| May 12, 2023 | -$ 0.21 | -$ 0.60 | $ 2,670.11 | |
| Mar 31, 2023 | - | $ 0.00 | $ 0.00 | |
| Mar 24, 2023 | -$ 0.23 | $ 0.33 | $ 1.03 | |
| Dec 31, 2022 | - | $ 0.0003300 | $ 0.00 |
Humacyte’s stock was trading at on Nov 5, 2026 a day before the last earnings report was released.
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Aug 12, 2026 | -$ 0.16 | $ 0.009 | $ 0.0075 | |
| May 13, 2026 | -$ 0.09 | $ 0.11 | $ 0.115 | |
| Mar 27, 2026 | -$ 0.13 | $ 0.0887 | $ 0.0891 | |
| Nov 12, 2025 | -$ 0.11 | $ 0.17 | $ 0.19 | |
| Aug 11, 2025 | -$ 0.24 | $ 0.4999 | $ 0.26 | |
| May 13, 2025 | $ 0.28 | $ 0.3168 | $ 0.5479 | |
| Mar 28, 2025 | -$ 0.16 | $ 0.5122 | $ 0.37 | |
| Nov 8, 2024 | -$ 0.33 | $ 1.88 | $ 1.79 | |
| Aug 13, 2024 | -$ 0.48 | $ 2.40 | $ 2.16 | |
| May 10, 2024 | -$ 0.29 | $ 0.7472 | $ 0.8501 | |
| Mar 22, 2024 | -$ 0.24 | $ 0.75 | $ 0.624 | |
| Nov 9, 2023 | -$ 0.25 | $ 0.49 | $ 0.49 | |
| Sep 30, 2023 | $ 0.00 | $ 0.7175 | $ 0.6612 | |
| Aug 14, 2023 | -$ 0.22 | $ 0.775 | $ 0.954 | |
| Jun 30, 2023 | $ 0.00 | $ 0.7071 | $ 0.74 | |
| May 12, 2023 | -$ 0.60 | $ 0.8875 | $ 0.89 | |
| Mar 31, 2023 | $ 0.00 | $ 0.7425 | $ 0.61 | |
| Mar 24, 2023 | $ 0.33 | $ 0.7509 | $ 0.72 | |
| Dec 31, 2022 | $ 0.0003300 | $ 0.3926 | $ 0.40 | |
| Nov 10, 2022 | $ 0.00 | $ 0.94 | $ 0.95 |
Humacyte released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Humacyte beat analysts’ expectations during the last earnings period by